The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma.
PET Clin
; 18(3): 309-314, 2023 Jul.
Article
en En
| MEDLINE
| ID: mdl-37029060
ABSTRACT
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy with worldwide high incidence and mortality. In more than 90% of cases, HCC arise from a cirrhotic liver that is mostly induced by viral diseases and especially in developed countries alcoholic steatohepatitis and non-alcoholic steatohepatitis. In contrast, cholangiocellular carcinoma (CCC) is a very rare cancer entity with a high mortality due to insidious onset. The only curative option for both cancer entities is a timely and definitive surgical therapy, which mandates an accurate early diagnosis. To this end, [18F]FDG PET/CT scan could demonstrate only little benefit, as there is an unmet clinical need for an alternative, pan-cancer agent for initial diagnostic work-up of CCC or evaluation of Milan criteria for HCC patients.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Neoplasias de los Conductos Biliares
/
Colangiocarcinoma
/
Carcinoma Hepatocelular
/
Hígado Graso
/
Neoplasias Hepáticas
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
PET Clin
Año:
2023
Tipo del documento:
Article